arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

ALNYLAM PHARMACEUTICALS, INC.

ALNY

$251.47 ▲ +7.18 (+2.94%) at close

19 Visible periods

28 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Good

Bullish

auto_awesome

Analytical Summary

ALNYLAM PHARMACEUTICALS, INC. shows strong fundamentals with top-quartile Return on Common Equity (%). The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap $32.9B

Dividend Yield —

Revenue Growth 65.2% ↗

Op. Margin 13.5% ↗

ROIC 61.7% ↗

FCF / Share $3.55 ↗

Trailing P/E 105.2x

Price / Book 42.2x

FCF Yield 1.4%

Debt / Equity —

info Valuation on last close. End-of-day price, Sep 22, 2026.

19-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$3.71B

↑ +65.2% —

Net Income Profit after all expenses

$313.75M

↑ +212.8% —

Operating Margin Operating profit as % of sales

13.5%

↑ +271.7% 64th

FCF / Share Free cash flow per share

$3.55

↑ +1164.8% —

trending_up

Bullish Indicators

Return on Common Equity (%)Return on Common Equity (%) is in the top quartile

warning

Bearish Risks

No bearish risks detected.

Health Breakdown

Profitability

Returns

Financial Health

Cash Quality ↑

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗	FY 2007 Dec 31, 2007 10-K ↗
Revenue Growth YoY (%)	65.2% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+715%)	23.0% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+187%)	76.2% Excellent → Excellent Stable Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+853%)	22.9% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+186%)	71.3% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+791%)	124.3% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1453%)	193.4% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+2317%)	-16.7% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-309%)	90.7% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1033%)	—	—	—	—	—	—	-0.5% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-106%)	4.5% Caution Caution Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-43%)	—	—
EPS Growth YoY (%)	N/M	38.1% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	62.2% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-29.2% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	3.5% Caution Caution Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Net Income Growth YoY (%)	N/M	36.8% Excellent ↑ Excellent Improving Year-over-year change in net income	61.1% Excellent ↑ Excellent Improving Year-over-year change in net income	-32.6% Weak ↓ Weak Declining Year-over-year change in net income	0.6% Caution ↑ Caution Improving Year-over-year change in net income	3.1% Caution ↑ Caution Improving Year-over-year change in net income	-16.4% Weak ↑ Weak Improving Year-over-year change in net income	-55.1% Weak ↓ Weak Declining Year-over-year change in net income	-19.7% Weak ↑ Weak Improving Year-over-year change in net income	-41.4% Weak ↑ Weak Improving Year-over-year change in net income	19.5% Good ↑ Good Improving Year-over-year change in net income	-303.9% Weak ↓ Weak Declining Year-over-year change in net income	15.8% Good ↑ Good Improving Year-over-year change in net income	-83.9% Weak ↓ Weak Declining Year-over-year change in net income	-32.5% Weak ↑ Weak Improving Year-over-year change in net income	8.6% Fair Fair Year-over-year change in net income	-81.3% Weak Weak Year-over-year change in net income	—	—
FCF Growth YoY (%)	N/M	N/M	N/M	16.9% Good Good Year-over-year change in free cash flow	-1.7% Weak Weak Year-over-year change in free cash flow	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Revenue CAGR 3Y (%)	53.0% Excellent → Excellent Stable Compound annual revenue growth over 3 years	38.6% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	54.8% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	67.8% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	124.2% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	76.3% Excellent Excellent Compound annual revenue growth over 3 years	67.0% Excellent Excellent Compound annual revenue growth over 3 years	—	—	—	—	—	—	—	—	—	—	—	—
Revenue CAGR 5Y (%)	49.8% Excellent ↓ Excellent Declining Compound annual revenue growth over 5 years	59.2% Excellent ↓ Excellent Declining Compound annual revenue growth over 5 years	89.5% Excellent ↑ Excellent Improving Compound annual revenue growth over 5 years	63.1% Excellent Excellent Compound annual revenue growth over 5 years	78.1% Excellent Excellent Compound annual revenue growth over 5 years	—	—	—	—	—	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 5 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗	FY 2007 Dec 31, 2007 10-K ↗
Operating Margin (%) (%)	13.5% Fair ↑ Fair Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-10%)	-7.9% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-152%)	-15.4% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-203%)	-75.7% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-605%)	-83.9% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-660%)	-168.1% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1221%)	-427.5% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2950%)	—	—	—	—	—	—	—	—	-44.1% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-394%)	-47.9% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-419%)	-28.9% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-293%)	—
Effective Tax Rate (%) (%)	2.9% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	26.3% Caution ↑ Caution Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-1.6% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.4% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.1% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.3% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.1% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.1% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	10.0% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	2.9% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	9.1% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	—	—	—
Profit Margin (%) (%)	8.4% Caution ↑ Caution Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-30%)	-12.4% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-203%)	-24.1% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-301%)	-109.0% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1009%)	-101.0% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-942%)	-174.1% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1551%)	-403.2% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3460%)	—	—	—	—	—	—	—	—	-43.5% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-462%)	-47.3% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-494%)	-27.3% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-327%)	—
FCF Margin (%) (%)	12.5% Fair ↑ Fair Improving Free cash flow as a percentage of revenue Optimal: > 10%	-1.9% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	2.3% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-59.1% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-85.0% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-139.1% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	-190.5% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	—	—	—	—	—	-89.0% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-76.7% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	56.9% Excellent Excellent Free cash flow as a percentage of revenue Optimal: > 10%	—
FCF / Net Income (x)	1.48x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	0.15x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	-0.10x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.54x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.84x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.80x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	0.47x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.91x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	0.99x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.91x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	0.81x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	1.17x Fair ↓ Fair Declining Free cash flow relative to reported net income Optimal: > 1x	1.53x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	2.05x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	1.62x Excellent Excellent Free cash flow relative to reported net income Optimal: > 1x	-2.08x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗	FY 2007 Dec 31, 2007 10-K ↗
Return on Invested Capital (%)	61.7% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	-194.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	129.9% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	498.0% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-120.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-81.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-65.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-62.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-28.3% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-46.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-23.4% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-38.9% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-33.4% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-87.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-36.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-22.0% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	-21.4% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—	—
Return on Capital (%) (%)	10.1% Good ↑ Good Improving Operating profit relative to total assets Optimal: > 10%	-4.2% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-7.4% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-22.1% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-19.5% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-24.3% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-39.2% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-51.7% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-25.1% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	—	-21.3% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-37.5% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-22.1% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-45.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-19.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-11.2% Weak Weak Operating profit relative to total assets Optimal: > 10%	-10.0% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—
Return on Common Equity (%) (%)	39.8% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+165%)	—	199.5% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+1230%)	—	-145.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1067%)	-84.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-663%)	-61.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-511%)	-58.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-490%)	-27.8% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-285%)	-44.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-397%)	-22.9% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-253%)	-38.5% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-357%)	-33.0% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-320%)	-79.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-627%)	-48.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-426%)	-27.5% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-283%)	-26.7% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-278%)	—	—

⚖️ Is the balance sheet risky? 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗	FY 2007 Dec 31, 2007 10-K ↗
Interest Coverage (x)	2.29x Caution ↑ Caution Improving Operating income divided by interest expense Optimal: > 5x	-2.62x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-2.33x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-5.03x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-4.95x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-9.80x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	—	-1051.19x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-205.80x Weak Weak Operating income divided by interest expense Optimal: > 5x	-387.40x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—	—	—	—	—	-31.92x Weak Weak Operating income divided by interest expense Optimal: > 5x	—
Net Debt (USD)	$-1.66B	$-966.43M	$-812.69M	$-866.39M	$-819.98M	$-496.58M	$-547.18M	$-420.15M	$-645.36M	$-193.62M	$-180.90M	$-75.18M	$-53.17M	$-51.41M	$-70.23M	$-74.60M	$-137.47M	$-191.79M	$-105.16M

📊 What does each share earn? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗	FY 2007 Dec 31, 2007 10-K ↗
Revenue per Share (USD)	$28.35	$17.61	$14.64	$8.53	$7.13	$4.29	—	—	—	—	—	—	—	—	—	—	—	—	—
Basic EPS, GAAP (USD)	$2.39	$-2.18	$-3.52	$-9.30	$-7.20	$-7.46	—	—	—	—	—	—	—	—	—	—	—	—	—
Free Cash Flow per Share (USD)	$3.55	$-0.33	$0.34	$-5.04	$-6.06	$-5.96	—	—	—	—	—	—	—	—	—	—	—	—	—
Book Value per Share (USD)	$5.96	$0.52	$-1.75	$-1.28	$4.89	$8.73	$12.82	$12.87	$17.72	—	$14.86	$12.13	$4.24	$2.55	$2.76	$3.74	$4.25	—	—
Tangible Book Value per Share (USD)	$5.96	$0.52	$-1.75	$-1.28	$4.89	$8.73	$12.82	$12.87	$17.72	—	$14.86	$12.13	$4.24	$2.55	$2.76	$3.74	$4.25	—	—
Basic Weighted Avg Shares (shares)	131.00M	127.65M	124.91M	121.69M	118.45M	114.99M	—	—	—	—	—	—	—	—	—	—	—	—	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗	FY 2007 Dec 31, 2007 10-K ↗
Working Capital (USD)	$2.58B	$2.11B	$2.01B	$1.92B	$2.11B	$2.03B	$1.36B	$1.02B	$1.62B	—	$1.04B	$651.03M	$200.16M	$77.21M	$71.04M	$152.09M	$182.80M	—	—
Total Equity (USD)	$789.18M	$67.09M	$-220.64M	$-158.22M	$588.20M	$1.02B	$1.44B	$1.30B	$1.77B	$920.22M	$1.26B	$936.27M	$270.35M	$134.05M	$118.00M	$158.23M	$177.97M	—	—

📋 What is driving earnings? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗	FY 2007 Dec 31, 2007 10-K ↗
Sales/Revenue/Turnover (USD)	$3.71B	$2.25B	$1.83B	$1.04B	$844.29M	$492.85M	$219.75M	$74.91M	$89.91M	$47.16M	—	—	—	—	—	$100.04M	$100.53M	$96.16M	—
Depreciation Expense (USD)	$54.80M	$55.10M	$51.60M	$39.10M	$36.80M	$30.20M	$16.60M	$12.80M	$11.90M	$9.60M	$19.05M	$11.93M	$10.23M	$9.04M	$5.12M	$4.94M	$5.99M	$5.73M	—
Net Income, GAAP (USD)	$313.75M	$-278.16M	$-440.24M	$-1.13B	$-852.82M	$-858.28M	$-886.12M	$-761.50M	$-490.87M	$-410.11M	$-290.07M	$-360.39M	$-89.22M	$-106.01M	$-57.65M	$-43.52M	$-47.59M	$-26.25M	—
Operating Cash Flow (USD)	$524.08M	$-8.31M	$104.16M	$-541.27M	$-641.69M	$-614.96M	$-278.43M	$-562.62M	$-382.79M	$-307.70M	—	—	$-68.66M	$-115.61M	$-87.07M	$-84.34M	$-72.14M	$65.49M	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 19 years · 72 quarters

ALNYLAM PHARMACEUTICALS, INC.

Analytical Summary

19-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare ALNY with peers